Cerus
CERS
#7472
Rank
C$0.57 B
Marketcap
C$3.00
Share price
1.40%
Change (1 day)
18.62%
Change (1 year)

Earnings for Cerus (CERS)

Earnings in 2025 (TTM): -C$10.25 Million

According to Cerus's latest financial reports the company's current earnings are C$0.19 Billion. In 2024 the company made an earning of -C$16.36 Million, an increase over its 2023 earnings that were of -C$39.85 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cerus from 1997 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$10.25 Million-37.39%
2024 -C$16.36 Million-58.95%
2023 -C$39.85 Million-20.74%
2022 -C$50.27 Million-25.7%
2021 -C$67.66 Million-11.99%
2020 -C$76.88 Million-14%
2019 -C$89.39 Million21.73%
2018 -C$73.44 Million-0.65%
2017 -C$73.92 Million-10.96%
2016 -C$83.02 Million4.24%
2015 -C$79.64 Million50.99%
2014 -C$52.75 Million-10.08%
2013 -C$58.66 Million184.13%
2012 -C$20.65 Million-7.91%
2011 -C$22.42 Million
2009 -C$31.66 Million-24.69%
2008 -C$42.04 Million-25.2%
2007 -C$56.21 Million330.54%
2006 -C$13.06 Million1.49%
2005 -C$12.87 Million-61.02%
2004 -C$33 Million
2002 -C$81.63 Million10.02%
2001 -C$74.2 Million34.25%
2000 -C$55.27 Million61.02%
1999 -C$34.33 Million-18.81%
1998 -C$42.28 Million93.08%
1997 -C$21.9 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Haemonetics
HAE
C$0.33 B-3,453.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-C$13.07 Million 31.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
C$4.50 B-45,284.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Utah Medical Products
UTMD
C$21.32 M-314.00%๐Ÿ‡บ๐Ÿ‡ธ USA